144 related articles for article (PubMed ID: 14635209)
1. Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation.
Tseng SB; Lin SF; Chang CS; Liu TC; Hsiao HH; Liu YC; Tsai HJ; Chen TP
Am J Hematol; 2003 Dec; 74(4):273-5. PubMed ID: 14635209
[TBL] [Abstract][Full Text] [Related]
2. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation.
Musso M; Porretto F; Crescimanno A; Polizzi V; Scalone R
Bone Marrow Transplant; 2004 Apr; 33(7):769-71. PubMed ID: 14755320
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation.
Müller BU; Tichelli A; Passweg JR; Nissen C; Wodnar-Filipowicz A; Gratwohl A
Bone Marrow Transplant; 1999 Jun; 23(11):1205-7. PubMed ID: 10382963
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
Yamaguchi M; Sakai K; Murata R; Ueda M
Bone Marrow Transplant; 2002 Oct; 30(8):539-41. PubMed ID: 12379896
[TBL] [Abstract][Full Text] [Related]
6. [Pure red cell aplasia after allogeneic peripheral blood stem cell transplantation: a case report and literature review].
Li C; Han M; Feng S
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):359-61. PubMed ID: 11721433
[TBL] [Abstract][Full Text] [Related]
7. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic peripheral blood stem cell transplantation in the treatment of severe aplastic anemia and severe infection.
Wan L; Yan S; Wang C; Yang X; Zhou Z; Gao Y; Cai Q; Zhang B
Chin Med J (Engl); 2003 May; 116(5):676-8. PubMed ID: 12875677
[TBL] [Abstract][Full Text] [Related]
9. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
10. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
11. The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann syndrome.
Ebihara Y; Manabe A; Tsuruta T; Ishikawa K; Hasegawa D; Ohtsuka Y; Kawasaki H; Ogami K; Wada Y; Kanda T; Tsuji K
Int J Hematol; 2007 Dec; 86(5):446-50. PubMed ID: 18192114
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of pure red cell aplasia with autologous stem cell transplantation.
Park JH; Spitzer T; Kuter DJ
Am J Hematol; 2007 Sep; 82(9):812-4. PubMed ID: 17546635
[TBL] [Abstract][Full Text] [Related]
15. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
[TBL] [Abstract][Full Text] [Related]
16. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
17. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
18. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
[TBL] [Abstract][Full Text] [Related]
19. Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back.
Rodríguez-Luaces M; Ferrá C; Martín-Henao G; Berlanga JJ; Grañena A; Gallardo D
Eur J Haematol; 2004 Sep; 73(3):162-8. PubMed ID: 15287912
[TBL] [Abstract][Full Text] [Related]
20. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.
Deotare UR; Vishwabandya A; Mathews V; George B; Srivastava A; Chandy M
Bone Marrow Transplant; 2006 Jun; 37(12):1149-50. PubMed ID: 16699532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
